Pfizer (NYSE: PFE) will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (NYSE: HLN), lowering its stake in
1 year ago
Pfizer’s (NYSE: PFE) experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of
NEW YORK – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE: PFE) COVID-19
NEW YORK – Executives from Pfizer (NYSE: PFE) and Amazon.com (NASDAQ: AMZN) see opportunities for working with U.S. Health Secretary
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two
U.S. sales of RSV vaccines from GSK (NYSE: GSK) and Pfizer (NYSE: PFE) are down significantly after regulators narrowed the
LONDON – On Monday, Pfizer (NYSE: PFE) won a bid in a London court to invalidate two of GSK’s (NYSE:
Pfizer (NYSE: PFE) sold a stake in British consumer healthcare group Haleon (NYSE: HLN) worth about $3.26 billion on Monday,
On Thursday, the European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer’s (NYSE: PFE) sickle cell disease drug
Pfizer’s (NYSE: PFE) decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death
LONDON – Pfizer (NYSE: PFE) and Moderna’s (NASDAQ: MRNA) legal battle over their rival COVID-19 vaccines will continue after London’s
